64Cu-SAR-Bombesin shows efficacy in detecting prostate cancer recurrence
From prep to follow-up: Key considerations for administering onabotulinumtoxinA
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
AI-based tool aims to optimize MRI use in prostate cancer diagnosis